Last reviewed · How we verify
NCT06278194
Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
NA trial testing Gasserian Ganglion Radiofrequency Thermocoagulation in Trigeminal Neuralgia in 30 participants. Currently enrolling.
15 July 2025
Quick facts
| Lead sponsor | Başakşehir Çam & Sakura City Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 March 2024 |
| Primary completion | 15 July 2025 |
| Estimated completion | 15 October 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Gasserian Ganglion Radiofrequency Thermocoagulation
Conditions studied
- Trigeminal Neuralgia — all drugs for Trigeminal Neuralgia →
- Gasserian Ganglion; Lesion — all drugs for Gasserian Ganglion; Lesion →
Sponsor
Başakşehir Çam & Sakura City Hospital
Who can join
Adults 40 to 85, any sex, with Trigeminal Neuralgia or Gasserian Ganglion; Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve branch of the trigeminal nerve. The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure. In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the procedure related with masseter muscle.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06278194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trigeminal Neuralgia
Currently open trials in the same condition.
- NCT07252453 — Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia · NA · active not recruiting
- NCT06620172 — CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia · NA · recruiting
- NCT06684275 — Comparison of Pulsed and Thermal Radiofrequency for Trigeminal Neuralgia · NA · recruiting
- NCT06849219 — Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia · Phase 4 · active not recruiting
- NCT06216886 — OnabotulinumtoxinA for Trigeminal Neuralgia · Phase 4 · recruiting
Other Başakşehir Çam & Sakura City Hospital trials
Trials by the same sponsor.
- NCT07403682 — M-TAPA vs ESPB for Postoperative Analgesia After Laparoscopic Cholecystectomy · NA · not yet recruiting
- NCT07199049 — Neuro-Mimic Indicators of Anesthesia Depth During General Anesthesia · not yet recruiting
- NCT07194707 — Effect of Operating Room Noise on BIS and Hemodynamics Under General Anesthesia · not yet recruiting
- NCT07327125 — Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery · NA · recruiting
- NCT07453641 — White Noise and Crying Duration After Invasive Procedures in Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06278194 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Başakşehir Çam & Sakura City Hospital
- Last refreshed: 5 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06278194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing